This Sacral Nerve Stimulation Devices market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.
The sacral nerve stimulation devices market size has grown rapidly in recent years. It will grow from $1.33 billion in 2024 to $1.49 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to the increasing prevalence of urinary and fecal incontinence, advancements in neuromodulation technology, rising awareness of non-surgical treatment options, favorable reimbursement policies, growing geriatric population, higher incidences of neurological disorders, and increased healthcare spending.
The sacral nerve stimulation devices market size is expected to see rapid growth in the next few years. It will grow to $2.31 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to improvements in reimbursement policies, greater acceptance of neuromodulation therapies, increasing preference for non-invasive or minimally invasive treatments, the exploration of sacral nerve stimulation devices, increasing preference among patients and healthcare providers, favorable regulatory environments, rising healthcare expenditure globally. Major trends in the forecast period include advances in miniaturization and implantable technologies, exploration of sacral nerve stimulation devices, development of external sacral nerve stimulation devices, patient education, and awareness, regulatory advances, market access, spinal cord stimulation, or peripheral nerve stimulation.
The growing prevalence of urological disorders is expected to boost the sacral nerve stimulation devices market. Urological disorders include various conditions affecting the urinary tract, kidneys, bladder, and prostate, ranging from acute to chronic. These disorders can be caused by multiple factors, including lifestyle issues such as poor diet, dehydration, and lack of exercise, which can contribute to kidney stones and other painful urinary tract conditions. Sacral nerve stimulation devices offer a minimally invasive treatment option for managing conditions such as urinary and fecal incontinence. For example, in April 2024, the National Institute of Diabetes and Digestive and Kidney Diseases reported that, on average, 651,446 individuals aged 65 and older are newly diagnosed with urinary incontinence annually. This growing prevalence of urological disorders is anticipated to drive the demand for sacral nerve stimulation devices.
Companies in the sacral nerve stimulation devices market are focusing on developing advanced products, such as next-generation sacral neuromodulation devices, to improve patient outcomes, enhance device efficacy, and minimize side effects. These cutting-edge devices offer better control and efficiency in stimulating sacral nerves. For instance, in February 2022, Medtronic plc, an Ireland-based medical device company, introduced the InterStim X. This next-generation device is designed for sacral neuromodulation therapy, addressing conditions such as overactive bladder (OAB), chronic fecal incontinence, and non-obstructive urinary retention. The InterStim X offers long-term, personalized treatment without the need for recharging, providing patients with up to a decade or more of therapy, enhancing convenience and adherence.
In January 2024, Boston Scientific Corporation, a US-based biotechnology firm, acquired Axonics for $3.7 billion. This acquisition aims to expand Boston Scientific's medical technology portfolio by integrating Axonics' specialized devices for treating urinary and bowel dysfunction. Axonics Inc., based in the U.S., is known for its implantable sacral neuromodulation (SNM) systems designed to address urinary urge incontinence and urinary urgency frequency (UUF).
Major companies operating in the sacral nerve stimulation devices market are Abbott, Medtronic plc, Boston Scientific Corporation, Livanova, Axonics Modulation Technologies, Laborie Medical Technologies, Beijing PINS Medical Co. Ltd., Nevro Corp., Cala Health, Micro Systems Technologies, Neuspera Medical, EndoStim Inc., InCube Labs, Soterix Medical, Synapse Biomedical Inc, Soin Neuroscience, Nuvectra Corporation, StimGuard LLC, Medzell, General Stim Inc.
North America was the largest region in the sacral nerve stimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sacral nerve stimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A sacral nerve stimulation device is a medical implant that uses electrical impulses to modulate nerves in the sacral area. It is used to treat conditions such as urinary incontinence and overactive bladder by regulating nerve activity, aiming to improve bladder function and enhance the quality of life for patients through targeted neurological intervention.
The main types of sacral nerve stimulation devices include electrical muscle stimulation devices and transcutaneous electrical nerve stimulation (TENS) devices. An electrical muscle stimulation device delivers electrical impulses to muscles via electrodes placed on the skin. Products in this category include external sacral nerve stimulation devices and implantable sacral nerve stimulation devices, which cater to different age groups such as pediatrics, adults, and geriatrics. These devices are used for various applications, including urinary incontinence, fecal incontinence, and other conditions, and are provided through hospitals, ambulatory surgical centers, and specialty clinics.
The sacral nerve stimulation devices market research report is one of a series of new reports that provides sacral nerve stimulation devices market statistics, including sacral nerve stimulation devices industry global market size, regional shares, competitors with a sacral nerve stimulation devices market share, detailed sacral nerve stimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the sacral nerve stimulation devices industry. This sacral nerve stimulation devices market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The sacral nerve stimulation devices market consists of sales of pulse generators, insulated wires, and electrode arrays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The sacral nerve stimulation devices market size has grown rapidly in recent years. It will grow from $1.33 billion in 2024 to $1.49 billion in 2025 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to the increasing prevalence of urinary and fecal incontinence, advancements in neuromodulation technology, rising awareness of non-surgical treatment options, favorable reimbursement policies, growing geriatric population, higher incidences of neurological disorders, and increased healthcare spending.
The sacral nerve stimulation devices market size is expected to see rapid growth in the next few years. It will grow to $2.31 billion in 2029 at a compound annual growth rate (CAGR) of 11.6%. The growth in the forecast period can be attributed to improvements in reimbursement policies, greater acceptance of neuromodulation therapies, increasing preference for non-invasive or minimally invasive treatments, the exploration of sacral nerve stimulation devices, increasing preference among patients and healthcare providers, favorable regulatory environments, rising healthcare expenditure globally. Major trends in the forecast period include advances in miniaturization and implantable technologies, exploration of sacral nerve stimulation devices, development of external sacral nerve stimulation devices, patient education, and awareness, regulatory advances, market access, spinal cord stimulation, or peripheral nerve stimulation.
The growing prevalence of urological disorders is expected to boost the sacral nerve stimulation devices market. Urological disorders include various conditions affecting the urinary tract, kidneys, bladder, and prostate, ranging from acute to chronic. These disorders can be caused by multiple factors, including lifestyle issues such as poor diet, dehydration, and lack of exercise, which can contribute to kidney stones and other painful urinary tract conditions. Sacral nerve stimulation devices offer a minimally invasive treatment option for managing conditions such as urinary and fecal incontinence. For example, in April 2024, the National Institute of Diabetes and Digestive and Kidney Diseases reported that, on average, 651,446 individuals aged 65 and older are newly diagnosed with urinary incontinence annually. This growing prevalence of urological disorders is anticipated to drive the demand for sacral nerve stimulation devices.
Companies in the sacral nerve stimulation devices market are focusing on developing advanced products, such as next-generation sacral neuromodulation devices, to improve patient outcomes, enhance device efficacy, and minimize side effects. These cutting-edge devices offer better control and efficiency in stimulating sacral nerves. For instance, in February 2022, Medtronic plc, an Ireland-based medical device company, introduced the InterStim X. This next-generation device is designed for sacral neuromodulation therapy, addressing conditions such as overactive bladder (OAB), chronic fecal incontinence, and non-obstructive urinary retention. The InterStim X offers long-term, personalized treatment without the need for recharging, providing patients with up to a decade or more of therapy, enhancing convenience and adherence.
In January 2024, Boston Scientific Corporation, a US-based biotechnology firm, acquired Axonics for $3.7 billion. This acquisition aims to expand Boston Scientific's medical technology portfolio by integrating Axonics' specialized devices for treating urinary and bowel dysfunction. Axonics Inc., based in the U.S., is known for its implantable sacral neuromodulation (SNM) systems designed to address urinary urge incontinence and urinary urgency frequency (UUF).
Major companies operating in the sacral nerve stimulation devices market are Abbott, Medtronic plc, Boston Scientific Corporation, Livanova, Axonics Modulation Technologies, Laborie Medical Technologies, Beijing PINS Medical Co. Ltd., Nevro Corp., Cala Health, Micro Systems Technologies, Neuspera Medical, EndoStim Inc., InCube Labs, Soterix Medical, Synapse Biomedical Inc, Soin Neuroscience, Nuvectra Corporation, StimGuard LLC, Medzell, General Stim Inc.
North America was the largest region in the sacral nerve stimulation devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sacral nerve stimulation devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the sacral nerve stimulation devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
A sacral nerve stimulation device is a medical implant that uses electrical impulses to modulate nerves in the sacral area. It is used to treat conditions such as urinary incontinence and overactive bladder by regulating nerve activity, aiming to improve bladder function and enhance the quality of life for patients through targeted neurological intervention.
The main types of sacral nerve stimulation devices include electrical muscle stimulation devices and transcutaneous electrical nerve stimulation (TENS) devices. An electrical muscle stimulation device delivers electrical impulses to muscles via electrodes placed on the skin. Products in this category include external sacral nerve stimulation devices and implantable sacral nerve stimulation devices, which cater to different age groups such as pediatrics, adults, and geriatrics. These devices are used for various applications, including urinary incontinence, fecal incontinence, and other conditions, and are provided through hospitals, ambulatory surgical centers, and specialty clinics.
The sacral nerve stimulation devices market research report is one of a series of new reports that provides sacral nerve stimulation devices market statistics, including sacral nerve stimulation devices industry global market size, regional shares, competitors with a sacral nerve stimulation devices market share, detailed sacral nerve stimulation devices market segments, market trends and opportunities, and any further data you may need to thrive in the sacral nerve stimulation devices industry. This sacral nerve stimulation devices market research report delivers a complete perspective on everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The sacral nerve stimulation devices market consists of sales of pulse generators, insulated wires, and electrode arrays. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Sacral Nerve Stimulation Devices Market Characteristics3. Sacral Nerve Stimulation Devices Market Trends and Strategies4. Sacral Nerve Stimulation Devices Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, and the Recovery from COVID-19 on the Market32. Global Sacral Nerve Stimulation Devices Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Sacral Nerve Stimulation Devices Market34. Recent Developments in the Sacral Nerve Stimulation Devices Market
5. Global Sacral Nerve Stimulation Devices Growth Analysis and Strategic Analysis Framework
6. Sacral Nerve Stimulation Devices Market Segmentation
7. Sacral Nerve Stimulation Devices Market Regional and Country Analysis
8. Asia-Pacific Sacral Nerve Stimulation Devices Market
9. China Sacral Nerve Stimulation Devices Market
10. India Sacral Nerve Stimulation Devices Market
11. Japan Sacral Nerve Stimulation Devices Market
12. Australia Sacral Nerve Stimulation Devices Market
13. Indonesia Sacral Nerve Stimulation Devices Market
14. South Korea Sacral Nerve Stimulation Devices Market
15. Western Europe Sacral Nerve Stimulation Devices Market
16. UK Sacral Nerve Stimulation Devices Market
17. Germany Sacral Nerve Stimulation Devices Market
18. France Sacral Nerve Stimulation Devices Market
19. Italy Sacral Nerve Stimulation Devices Market
20. Spain Sacral Nerve Stimulation Devices Market
21. Eastern Europe Sacral Nerve Stimulation Devices Market
22. Russia Sacral Nerve Stimulation Devices Market
23. North America Sacral Nerve Stimulation Devices Market
24. USA Sacral Nerve Stimulation Devices Market
25. Canada Sacral Nerve Stimulation Devices Market
26. South America Sacral Nerve Stimulation Devices Market
27. Brazil Sacral Nerve Stimulation Devices Market
28. Middle East Sacral Nerve Stimulation Devices Market
29. Africa Sacral Nerve Stimulation Devices Market
30. Sacral Nerve Stimulation Devices Market Competitive Landscape and Company Profiles
31. Sacral Nerve Stimulation Devices Market Other Major and Innovative Companies
35. Sacral Nerve Stimulation Devices Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Sacral Nerve Stimulation Devices Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on sacral nerve stimulation devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for sacral nerve stimulation devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The sacral nerve stimulation devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include: the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Type: Electrical Muscle Stimulation; Transcutaneous Electrical Nerve Stimulation2) By Product: External Sacral Nerve Stimulation (SNS) Devices; Implantable Sacral Nerve Stimulation (SNS) Devices
3) By Age: Pediatrics; Adults; Geriatrics
4) By Application: Urinary Incontinence; Fecal Incontinence; Other Applications
5) By End User: Hospital; Ambulatory Surgical Centers; Specialty Clinics
Subsegments:
1) By Electrical Muscle Stimulation: Surface Electrical Muscle Stimulation; Implantable Electrical Muscle Stimulation2) By Transcutaneous Electrical Nerve Stimulation: Conventional TENS; Burst Mode TENS; Modulated TENS
Key Companies Mentioned: Abbott; Medtronic plc; Boston Scientific Corporation; Livanova; Axonics Modulation Technologies
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
The major companies featured in this Sacral Nerve Stimulation Devices market report include:- Abbott
- Medtronic plc
- Boston Scientific Corporation
- Livanova
- Axonics Modulation Technologies
- Laborie Medical Technologies
- Beijing PINS Medical Co. Ltd.
- Nevro Corp.
- Cala Health
- Micro Systems Technologies
- Neuspera Medical
- EndoStim Inc.
- InCube Labs
- Soterix Medical
- Synapse Biomedical Inc
- Soin Neuroscience
- Nuvectra Corporation
- StimGuard LLC
- Medzell
- General Stim Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 200 |
Published | April 2025 |
Forecast Period | 2025 - 2029 |
Estimated Market Value ( USD | $ 1.49 Billion |
Forecasted Market Value ( USD | $ 2.31 Billion |
Compound Annual Growth Rate | 11.6% |
Regions Covered | Global |
No. of Companies Mentioned | 21 |